- Previous Close
21.66 - Open
22.26 - Bid 15.92 x 200
- Ask 28.22 x 200
- Day's Range
21.92 - 22.37 - 52 Week Range
16.67 - 29.15 - Volume
37,035 - Avg. Volume
944,537 - Market Cap (intraday)
1.608B - Beta (5Y Monthly) 1.62
- PE Ratio (TTM)
-- - EPS (TTM)
-2.57 - Earnings Date Apr 29, 2025 - May 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
32.09
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
www.schrodinger.com891
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SDGR
View More
Performance Overview: SDGR
Trailing total returns as of 3/12/2025, which may include dividends or other distributions. Benchmark is S&P 500 .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SDGR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SDGR
View MoreValuation Measures
Market Cap
1.58B
Enterprise Value
1.35B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.59
Price/Book (mrq)
3.76
Enterprise Value/Revenue
6.50
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-90.16%
Return on Assets (ttm)
-16.09%
Return on Equity (ttm)
-38.58%
Revenue (ttm)
207.54M
Net Income Avi to Common (ttm)
-187.12M
Diluted EPS (ttm)
-2.57
Balance Sheet and Cash Flow
Total Cash (mrq)
352.12M
Total Debt/Equity (mrq)
27.96%
Levered Free Cash Flow (ttm)
-201.95M
Research Analysis: SDGR
View MoreCompany Insights: SDGR
SDGR does not have Company Insights
Research Reports: SDGR
View MoreWhat does Argus have to say about SDGR?
SCHRODINGER INC has an Investment Rating of SELL; a target price of $17.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $17.00
SCHRODINGER INC has an Investment Rating of SELL; a target price of $17.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $21.00
SCHRODINGER INC has an Investment Rating of SELL; a target price of $21.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetWhat does Argus have to say about SDGR?
SCHRODINGER INC has an Investment Rating of SELL; a target price of $20.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice Target